SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
- Conditions
- Melanoma (Skin)
- Interventions
- Procedure: Surgery
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-01-13
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 77
- Registration Number
- NCT00002860
- Locations
- 🇺🇸
William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States
🇺🇸David C. Pratt Cancer Center at St. John's Mercy, St. Louis, Missouri, United States
🇺🇸Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States
S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
- Conditions
- Precancerous/Nonmalignant ConditionProstate Cancer
- Interventions
- Drug: L-selenomethionine placeboDrug: L-selenomethionine
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-02-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 619
- Registration Number
- NCT00030901
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 33
- Registration Number
- NCT00049179
- Locations
- 🇺🇸
Charles B. Eberhart Cancer Center at DeKalb Medical Center, Decatur, Georgia, United States
🇺🇸Kennestone Cancer Center at Wellstar Kennestone Hospital, Marietta, Georgia, United States
🇺🇸David C. Pratt Cancer Center at St. John's Mercy, St. Louis, Missouri, United States
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
- Conditions
- Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-01-30
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 183
- Registration Number
- NCT00017147
- Locations
- 🇺🇸
Freeman Cancer Institute at Freeman Health System, Joplin, Missouri, United States
🇺🇸Great Falls Clinic, Great Falls, Montana, United States
🇺🇸Glacier Oncology, PLLC, Kalispell, Montana, United States
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
- Conditions
- Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 77
- Registration Number
- NCT00045630
- Locations
- 🇺🇸
Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸Hurley Medical Center, Flint, Michigan, United States
S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-04-10
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 78
- Registration Number
- NCT00006248
- Locations
- 🇺🇸
MBCCOP - Gulf Coast, Mobile, Alabama, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
- Conditions
- Breast CancerEndometrial Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-10-31
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 313
- Registration Number
- NCT00002920
- Locations
- 🇺🇸
CCOP - Beaumont, Royal Oak, Michigan, United States
🇺🇸Veterans Affairs Medical Center - Loma Linda (Pettis), Loma Linda, California, United States
🇺🇸Veterans Affairs Medical Center - Asheville, Asheville, North Carolina, United States
S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
- Conditions
- Cancer-related Problem/ConditionPainHead and Neck Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 23
- Registration Number
- NCT00006994
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States
🇺🇸Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States
🇺🇸Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
- Conditions
- Small Intestine CancerUnspecified Adult Solid Tumor, Protocol SpecificLymphoma
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 78
- Registration Number
- NCT00049400
- Locations
- 🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸Community Oncology Group at Cleveland Clinic Cancer Center, Independence, Ohio, United States
🇺🇸Brooke Army Medical Center, Fort Sam Houston, Texas, United States
S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 71
- Registration Number
- NCT00023777
- Locations
- 🇺🇸
MBCCOP - Gulf Coast, Mobile, Alabama, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, United States